Acelyrin Inc (SLRN)
4.385
-0.24
(-5.29%)
USD |
NASDAQ |
May 17, 16:00
4.385
0.00 (0.00%)
After-Hours: 20:00
Acelyrin Price to Book Value: 0.675 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.675 |
| May 16, 2024 | 0.7119 |
| May 15, 2024 | 0.7288 |
| May 14, 2024 | 0.7273 |
| May 13, 2024 | 0.7211 |
| May 10, 2024 | 0.7196 |
| May 09, 2024 | 0.7503 |
| May 08, 2024 | 0.7365 |
| May 07, 2024 | 0.7095 |
| May 06, 2024 | 0.6711 |
| May 03, 2024 | 0.6681 |
| May 02, 2024 | 0.6527 |
| May 01, 2024 | 0.6527 |
| April 30, 2024 | 0.6419 |
| April 29, 2024 | 0.6512 |
| April 26, 2024 | 0.6512 |
| April 25, 2024 | 0.6512 |
| April 24, 2024 | 0.7018 |
| April 23, 2024 | 0.7064 |
| April 22, 2024 | 0.7402 |
| April 19, 2024 | 0.7694 |
| April 18, 2024 | 0.7494 |
| April 17, 2024 | 0.7709 |
| April 16, 2024 | 0.7894 |
| April 15, 2024 | 0.8477 |
| Date | Value |
|---|---|
| April 12, 2024 | 0.8247 |
| April 11, 2024 | 0.8846 |
| April 10, 2024 | 0.8754 |
| April 09, 2024 | 0.9138 |
| April 08, 2024 | 0.9291 |
| April 05, 2024 | 0.9322 |
| April 04, 2024 | 0.9813 |
| April 03, 2024 | 1.018 |
| April 02, 2024 | 1.004 |
| April 01, 2024 | 1.023 |
| March 28, 2024 | 1.012 |
| March 27, 2024 | 1.012 |
| March 26, 2024 | 0.9966 |
| March 25, 2024 | 1.010 |
| March 22, 2024 | 1.033 |
| March 21, 2024 | 1.160 |
| March 20, 2024 | 1.241 |
| March 19, 2024 | 1.187 |
| March 18, 2024 | 1.136 |
| March 15, 2024 | 1.169 |
| March 14, 2024 | 1.174 |
| March 13, 2024 | 1.229 |
| March 12, 2024 | 1.236 |
| March 11, 2024 | 1.238 |
| March 08, 2024 | 1.115 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6419
Minimum
Apr 30 2024
3.498
Maximum
Aug 22 2023
1.492
Average
1.183
Median
Nov 14 2023
Price to Book Value Benchmarks
| Lexicon Pharmaceuticals Inc | 2.215 |
| Eagle Pharmaceuticals Inc | -- |
| Avalo Therapeutics Inc | -- |
| Design Therapeutics Inc | 0.9243 |
| CEL-SCI Corp | 4.808 |
Price to Book Value Related Metrics
| Price | 4.385 |
| Earnings Yield | -54.21% |
| Market Cap | 434.73M |